Correction: Statins for primary prevention of cardiovascular events in people with HIV: target trial and modelling study
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHIV-related health complications and treatments · Lipoproteins and Cardiovascular Health
Yebyo HG, Guenthard HF, Rehfuess EA, et al. Statins for primary prevention of cardiovascular events in people with HIV: target trial and modelling study: BMJ Med 2025;4:e001132.
In this research article by Yebyo and colleagues (BMJMED 2025;4:e001132. doi: 10.1136/bmj-2024-001132, published 8 May), the second author's name has been corrected to Huldrych F Günthard.